Duke University's Office for Translation & Commercialization Reports Record-breaking Year

Why It Matters:

Duke University's OTC plays a crucial role in translating and commercializing the university's intellectual property. The record-breaking revenue demonstrates the value of Duke's research and supports further innovation and research.

The Details:

• FY23 licensing revenue reached $102.5 million, distributed back to Duke inventors, labs, departments, and schools.

• OTC received 325 invention disclosures, signed 90 agreements, and was issued 104 patents.

• OTC helped spin out 15 new start-up companies, supporting innovation from various academic units.

• Duke start-ups raised over $395 million, with three companies being acquired.

• Duke Capital Partners (DCP), which joined OTC last fiscal year, made 12 investments totaling $10.8 million, with $7.5 million going to Duke-owned intellectual property companies.

• DCP portfolio companies have raised $1.3 billion and are valued at $5.0 billion.

• OTC launched the Gilhuly Accelerator Fund to support early-stage technologies, allocating over $1 million to 14 ongoing projects.

• OTC's experiential learning programs welcomed a record-breaking cohort of 60 early career trainees.

Conclusion:

Duke University's OTC has achieved significant success in commercializing intellectual property, supporting inventors, and fostering innovation. The record-breaking revenue and successful start-up ventures highlight Duke's commitment to translating research into impactful solutions.